BioPharma
Pharma Packaging Soars to $464B: Growth Factors Revealed
Industry analysts anticipate substantial growth in the global pharmaceutical packaging market, which is projected to reach USD 464.4 billion by 2031. This surge is supported by increasing demand for innovative packaging, reflected in a notable CAGR of 14.8% over...
BioPharma
Pharma Packaging Equipment Market to Reach $13.3B by 2033
Driven by the growing importance and rising demand for pharmaceutical packaging, the global pharmaceutical packaging equipment market is projected to reach approximately US$ 13.3 billion by 2033. This momentum is expected to open new opportunities for the sector, supporting...
BioPharma
Sustainable Lab Automation : Altering Diagnostics By 2030
The Sustainable Development Goals (SDGs) included in the UN 2030 Agenda also address the environmental, social, and economic aspects of development. In this sense, the diagnostic and healthcare industries proceed to convert the SDG Global Data agenda into development...
Business & Industry
Global Lab Instrument Market Forecast to Grow by 6.3% CAGR
An analysis by BCC Research shows that the market for analytical laboratory instruments will grow at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028, rising from $60.9 billion in 2023 to $82.5 billion by 2028.
The...
Business & Industry
GSK Licences COPD Drug from Empirico for $85 Million Upfront
In just a space of 24 hours, GSK, in its second pipeline-expanding deal, has gone on to license the rights to a drug for chronic obstructive pulmonary disease – COPD from Empirico, the US biotech, for $85 million, and...
BioPharma
CDMO Market for AAV Therapies to Hit $2.566 Billion By 2033
With a focus on Adeno-Associated Virus (AAV), the worldwide market for Contract Development and Manufacturing Organizations (CDMMOs) that biomanufacture cell and gene therapies has shown spectacular development, estimated to reach $0.2313 billion in 2022. Based on projections, this market...
BioPharma
Pharmaceutical CMO Market is Set for a 7.29% CAGR by 2028
It is projected that the market for pharmaceutical contract manufacturing organizations (CMOs) would expand at a compound annual growth rate (CAGR) of 7.29 percent until the year 2028. This rise may be ascribed to the expanded pharmaceutical industry, which...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















